Patent Assignment
Reel/Frame 019943/0333
Assignment of Assignor's Interest
Recorded: 2007-10-11
Pages: 8
Assignor
SANOFI-AVENTIS U.S. LLC.
Executed: 2007-10-09
Assignee
SRI INTERNATIONAL
333 RAVENSWOOD AVENUE, MENLO PARK, CALIFORNIA, 94025
Covered Properties
(6)
Oral Gel Capsule Formulation of 1,2,4-Benzotriazine Oxides
Patent:
5,597,582 →
Application:
08/527,233 →
Method of Cancer Tumor Treatment by Slow Release Delivery of 1,2,4-Benzotriazine Oxides to Tumor Site
Patent:
5,637,085 →
Application:
08/560,856 →
1,2,4-Benzotriazine Oxides Formulations
Patent:
5,827,850 →
Application:
08/837,637 →
Method of Treating a Tumor
Patent:
6,063,780 →
Application:
09/031,692 →
1,2,4-Benzotriazine Oxides Formulations
Patent:
6,153,610 →
Application:
09/157,905 →
Method of treating a tumor
Patent:
6,319,923 →
Application:
09/505,043 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Dec 20, 1999
From: SANOFI PHARMACEUTICALS, INC.
To: SANOFI-SYNTHELABO INC.
Reel/Frame 010470/0004 →
Assignment of Assignor's Interest
May 3, 2006
From: SANOFI-SYNTHELABO INC.
To: SANOFI-AVENTIS U.S. LLC
Reel/Frame 017564/0129 →
Assignment of Assignor's Interest
Jun 20, 2007
From: SANOFI-SYNTHELABO INC.
To: SANOFI-AVENTIS U.S. LLC.
Reel/Frame 019448/0842 →